Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects
Clinical trial NCT03485092 · COMPLETED
Trial details
- NCT number
- NCT03485092
- Sponsor
- NHS Greater Glasgow and Clyde
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2020-03-28
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.